{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:26:27Z","timestamp":1768271187990,"version":"3.49.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>There are no universally accepted agents that will substantially increase bone mass in osteoporotic patients. A number of peptides important in normal bone formation, such as members of the transforming growth factor-\u03b2 superfamily, are not satisfactory for this purpose either because their beneficial effects are predominantly local or there is systemic toxicity associated with their administration. We have examined the effects of exogenous fibroblast growth factor-1 and -2 (FGF-1 and FGF-2) on bone in vivo, since FGFs have been shown recently to be essential for normal skeletal development. FGF-1 was injected daily (0.2 mg\/kg intravenously) for 28 days into the tail vein of adult female rats immediately following and 6 months after sham operation or ovariectomy (OVX). In rats treated immediately post-OVX, OVX produced more than a 30% decrease in tibial bone density, which was prevented by FGF-1 and estrogen. However, FGF-1 also had an anabolic effect. In sham-operated rats, FGF-1 increased bone density to 2-fold, whereas estrogen had no effect. In rats 6 months post-OVX, severe bone loss and disruption of trabecular microarchitecture occurred similar to that seen in patients with severe osteoporosis. In these rats, administration of FGF-1 induced extensive new woven bone formation with new trabecular-like structures filling much of the marrow spaces, and bone density in the tibial metaphysis increased 3-fold. FGF-1 and FGF-2 were also administered subcutaneously over the calvaria of mice in doses of 2\u20132000 \u03bcg\/day for 3 days and shown to produce substantial increases in bone formation when examined morphologically. Thus, we conclude that both local and systemic FGF-1 increases new bone formation and bone density, and systemic FGF-1 also appears to restore bone microarchitecture and prevent bone loss associated with estrogen-withdrawal.<\/jats:p>","DOI":"10.1359\/jbmr.1999.14.6.953","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T01:56:24Z","timestamp":1146102984000},"page":"953-959","source":"Crossref","is-referenced-by-count":97,"title":["Systemic Administration of Acidic Fibroblast Growth Factor (FGF-1) Prevents Bone Loss and Increases New Bone Formation in Ovariectomized Rats"],"prefix":"10.1093","volume":"14","author":[{"given":"C. R.","family":"Dunstan","sequence":"first","affiliation":[{"name":"Amgen, Thousand Oaks, California, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Boyce","sequence":"additional","affiliation":[{"name":"Rhone-Poulenc Rorer, Collegeville, Pennsylvania, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. F.","family":"Boyce","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center, San Antonio, Texas, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. R.","family":"Garrett","sequence":"additional","affiliation":[{"name":"OsteoSA, San Antonio, Texas, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Izbicka","sequence":"additional","affiliation":[{"name":"Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, Texas, U.S.A."},{"name":"University of Texas Health Science Center, San Antonio, Texas, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. H.","family":"Burgess","sequence":"additional","affiliation":[{"name":"Department of Tissue Biology, Holland Laboratory, American Red Cross, Rockville, Maryland, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. R.","family":"Mundy","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center, San Antonio, Texas, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024020713372591200_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of the FGFR3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"key":"2024020713372591200_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0168-9525(00)89088-5","article-title":"Fibroblast growth factor receptor mutations in human skeletal disorders","volume":"11","author":"Muenke","year":"1995","journal-title":"Trends Genet"},{"key":"2024020713372591200_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0092-8674(95)90352-6","article-title":"Fibroblast growth factors induce additional limb development from the flank of chick embryos","volume":"80","author":"Cohn","year":"1995","journal-title":"Cell"},{"key":"2024020713372591200_bib4","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1210\/endo-121-6-1917","article-title":"Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor","volume":"121","author":"Rodan","year":"1987","journal-title":"Endocrinology"},{"key":"2024020713372591200_bib5","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1210\/endo-124-3-1539","article-title":"Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix","volume":"124","author":"Globus","year":"1989","journal-title":"Endocrinology"},{"issue":"Suppl 1","key":"2024020713372591200_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000213717","article-title":"Decreased mitogenic and osteogenic responsiveness of calvarial osteoblasts isolated from aged rats to basic fibroblast growth factor","volume":"41","author":"Kato","year":"1995","journal-title":"Gerontology"},{"key":"2024020713372591200_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/08977199308991583","article-title":"In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats","volume":"9","author":"Mayahara","year":"1993","journal-title":"Growth Factors"},{"key":"2024020713372591200_bib8","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/endo.136.3.7867582","article-title":"Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats","volume":"136","author":"Nakamura","year":"1995","journal-title":"Endocrinology"},{"key":"2024020713372591200_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s002640050207","article-title":"Stimulation of bone formation by intraosseous injection of basic fibroblast growth factor in ovariectomised rats","volume":"22","author":"Nakamura","year":"1998","journal-title":"Int Orthop"},{"key":"2024020713372591200_bib10","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1083\/jcb.111.5.2129","article-title":"Possible dissociation of the heparin binding and mitogenic activities of heparin-binding (acid fibroblast) growth factor-1 from its receptor binding and mitogenic activities by site-directed mutagenesis of a single lysine residue","volume":"111","author":"Burgess","year":"1990","journal-title":"J Cell Biol"},{"key":"2024020713372591200_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jcb.240450203","article-title":"Structure-function studies of heparin-binding (acidic fibroblast) growth factor-I using site-directed mutagenesis","volume":"45","author":"Burgess","year":"1991","journal-title":"J Cell Biochem"},{"key":"2024020713372591200_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/mrd.1080390110","article-title":"Structure-function studies of FGF-1: Dissociation and partial reconstitution of certain of its biological activities","volume":"39","author":"Burgess","year":"1994","journal-title":"Mol Reprod Dev"},{"key":"2024020713372591200_bib13","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1210\/endo-125-3-1142","article-title":"Effects of interleukin-1 on bone turnover in normal mice","volume":"125","author":"Boyce","year":"1989","journal-title":"Endocrinology"},{"key":"2024020713372591200_bib14","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1210\/endo-124-6-2991","article-title":"In vivo stimulation of bone formation by transforming growth factor-beta","volume":"124","author":"Noda","year":"1989","journal-title":"Endocrinology"},{"key":"2024020713372591200_bib15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/jbmr.5650051013","article-title":"In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice","volume":"10","author":"Marcelli","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2024020713372591200_bib16","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1016\/S0021-9258(18)67143-1","article-title":"Growth factors in bone matrix","volume":"261","author":"Hauschka","year":"1986","journal-title":"J Biol Chem"},{"key":"2024020713372591200_bib17","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1073\/pnas.84.7.2024","article-title":"Modulation of transforming growth factor beta activity in bone cultures by osteotropic hormones","volume":"84","author":"Pfeilschifter","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024020713372591200_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"2024020713372591200_bib19","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1957172","article-title":"Hypotensive activity of fibroblast growth factor","volume":"254","author":"Cuevas","year":"1991","journal-title":"Science"},{"key":"2024020713372591200_bib20","doi-asserted-by":"crossref","first-page":"71S","DOI":"10.1016\/8756-3282(95)00182-D","article-title":"The effects of cytokines and growth factors on osteoblastic cells","volume":"17","author":"Mundy","year":"1995","journal-title":"Bone"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.1999.14.6.953","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/14\/6\/953\/56599830\/5650140614.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/14\/6\/953\/56599830\/5650140614.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:58:21Z","timestamp":1710341901000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/14\/6\/953-959\/7515013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6,1]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[1999,6,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.1999.14.6.953","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,6,1]]},"published":{"date-parts":[[1999,6,1]]}}}